ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

NXNN Nexeon Medsystems Inc (CE)

0.0001
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Nexeon Medsystems Inc (CE) USOTC:NXNN OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0001 0.00 01:00:00

Statement of Changes in Beneficial Ownership (4)

10/10/2017 9:24pm

Edgar (US Regulatory)


FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

NEITZEL MICHAEL
2. Issuer Name and Ticker or Trading Symbol

NEXEON MEDSYSTEMS INC [ NXNN ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

1910 PACIFIC AVENUE, SUITE 20000
3. Date of Earliest Transaction (MM/DD/YYYY)

10/1/2017
(Street)

DALLAS, TX 75201
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
COMMON STOCK                  585000   I   See Footnote   (1)
COMMON STOCK                  30000   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
OPTIONS   (2) $1.00   10/1/2017     J   (2)    12500       10/1/2017   10/1/2021   COMMON STOCK   12500   $0   37500   D    

Explanation of Responses:
(1)  Mr Neitzel beneficially owns the securities of the Company held by Yorkville MGB Investments, LLC. as Mr. Neitzel is the Managing Partner of Yorkville MGB Investments, LLC and in such capacity has the voting and dispositive power over the securities held by such entity.
(2)  Pursuant to the Director Services Agreement dated January 1, 2017, entered into between Mr. Neitzel and the Company, at the end of each 3-month period that he serves as a Director of the Company, the Company will grant to Mr. Neitzel an option (each "an Option") to purchase 12,500 shares of the Company's restricted Common Stock, at a price equal to $1.00 per share or in the alternative the price per share (the "Strike Price") of the Company's then current 409a valuation. Once established the Strike Price shall remain effective for any and all Options granted as a result of being a Director until there is a change in any future 409a valuation. Such 409a valuations shall not be retroactive for options previously granted. The term of each Option shall be for a period of four (4) years from the date of issue.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
NEITZEL MICHAEL
1910 PACIFIC AVENUE, SUITE 20000
DALLAS, TX 75201
X



Signatures
/s/ Michael Neitzel 10/10/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1 Year Nexeon Medsystems (CE) Chart

1 Year Nexeon Medsystems (CE) Chart

1 Month Nexeon Medsystems (CE) Chart

1 Month Nexeon Medsystems (CE) Chart